- Device
- Pipeline™ Vantage Embolization Device with Shield Technology™
- Applicant
- Micro Therapeutics, Inc. d/b/a ev3 Neurovascular
- PMA number
- P100018
- Supplement
- S048
- Product code
- OUT
- Generic name
- Intracranial aneurysm flow diverter
- Decision date
- 2025-08-14
- Decision code
- APPR
- Date received
- 2025-01-29
- Supplement type
- Normal 180 Day Track No User Fee
- Supplement reason
- Postapproval Study Protocol
- Approval order statement
- Approval for changes to the post-approval study (PAS) protocol for Pipeline Vantage device following the removal of the Vantage 027 devices, including updates to include additional follow-up imaging to assess for braid deformation events.